PIRO, SALVATORE
 Distribuzione geografica
Continente #
NA - Nord America 12.673
EU - Europa 6.715
AS - Asia 6.259
SA - Sud America 1.230
AF - Africa 891
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 6
Totale 27.793
Nazione #
US - Stati Uniti d'America 12.244
SG - Singapore 3.157
RU - Federazione Russa 2.044
IT - Italia 1.887
CN - Cina 1.402
BR - Brasile 1.023
IE - Irlanda 899
VN - Vietnam 584
UA - Ucraina 577
CI - Costa d'Avorio 442
FR - Francia 340
CA - Canada 323
IN - India 303
GB - Regno Unito 184
KR - Corea 184
DE - Germania 179
SE - Svezia 163
NG - Nigeria 160
SN - Senegal 150
BD - Bangladesh 131
FI - Finlandia 81
TR - Turchia 75
AR - Argentina 72
HK - Hong Kong 68
JP - Giappone 63
PL - Polonia 63
NL - Olanda 62
MX - Messico 53
IQ - Iraq 46
ZA - Sudafrica 46
UZ - Uzbekistan 44
AT - Austria 37
EC - Ecuador 36
ES - Italia 34
PK - Pakistan 30
CO - Colombia 27
CH - Svizzera 26
CL - Cile 21
LT - Lituania 21
MA - Marocco 21
IR - Iran 20
LB - Libano 20
ID - Indonesia 19
GR - Grecia 18
KE - Kenya 18
AU - Australia 17
BJ - Benin 17
VE - Venezuela 17
SA - Arabia Saudita 15
PY - Paraguay 13
BG - Bulgaria 11
AL - Albania 10
AZ - Azerbaigian 10
BE - Belgio 10
CZ - Repubblica Ceca 10
EG - Egitto 10
JM - Giamaica 9
PH - Filippine 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
BO - Bolivia 8
NP - Nepal 8
PA - Panama 8
UY - Uruguay 8
HR - Croazia 7
JO - Giordania 7
MY - Malesia 7
RO - Romania 7
RS - Serbia 7
TH - Thailandia 7
ET - Etiopia 6
EU - Europa 6
KZ - Kazakistan 6
CR - Costa Rica 5
HU - Ungheria 5
IL - Israele 5
OM - Oman 5
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
KW - Kuwait 4
MK - Macedonia 4
PE - Perù 4
PS - Palestinian Territory 4
SI - Slovenia 4
SV - El Salvador 4
DK - Danimarca 3
DZ - Algeria 3
GD - Grenada 3
GE - Georgia 3
HN - Honduras 3
LV - Lettonia 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BB - Barbados 2
BY - Bielorussia 2
GT - Guatemala 2
IS - Islanda 2
LU - Lussemburgo 2
LY - Libia 2
Totale 27.754
Città #
Dallas 2.079
Singapore 1.881
Santa Clara 1.340
Chandler 1.014
San Jose 927
Dublin 898
Moscow 842
Jacksonville 624
Ashburn 616
Chicago 451
Abidjan 442
Boardman 361
Catania 319
Lauterbourg 246
Cambridge 242
Lawrence 242
Andover 240
Los Angeles 234
Beijing 232
Hefei 222
Nanjing 208
Civitanova Marche 201
Kochi 189
Toronto 186
Ho Chi Minh City 182
Seoul 181
Wilmington 155
Milan 153
Dakar 150
Rome 149
Des Moines 135
New York 132
Council Bluffs 130
Hanoi 127
São Paulo 94
San Mateo 91
Buffalo 90
Abuja 81
Houston 81
Padova 64
Dong Ket 63
Palermo 63
The Dalles 62
Lagos 61
Nanchang 61
Shenyang 59
Hong Kong 58
Tokyo 58
Orem 55
Bremen 54
Hebei 51
Montreal 50
Warsaw 50
Columbus 48
Lappeenranta 43
Ottawa 43
Saint Petersburg 43
Munich 39
Phoenix 39
Denver 38
Jiaxing 38
Changsha 36
Brooklyn 34
Chennai 34
Seattle 34
Stockholm 34
Johannesburg 32
San Francisco 32
Atlanta 31
Belo Horizonte 31
London 31
Poplar 31
Rio de Janeiro 30
San Giovanni la Punta 30
Amsterdam 28
Da Nang 28
Boston 25
Carrara 25
Frankfurt am Main 25
Helsinki 25
Messina 25
Istanbul 24
Tianjin 23
Tashkent 22
Rosolini 21
Boydton 19
Washington 19
Charlotte 18
Dhaka 18
Manchester 18
Mumbai 18
Naples 18
Port Harcourt 18
Brasília 17
Cotonou 17
Mexico City 17
Redondo Beach 17
Ankara 16
Baghdad 16
Nairobi 16
Totale 18.260
Nome #
IL DIABETE MELLITO AUMENTA LE RESISTENZE ARTERIOSE RENALI NEI PAZIENTI CON CIRROSI EPATICA 718
Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease 391
1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease 263
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 224
Controlling Nutritional Status (CONUT) Score as a Potential Prognostic Indicator of In-Hospital Mortality, Sepsis and Length of Stay in an Internal Medicine Department 205
An Uncharacterised lncRNA Coded by the ASAP1 Locus Is Downregulated in Serum of Type 2 Diabetes Mellitus Patients 193
The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia 185
Chronic exposure to palmitate impairs insulin signaling in an intestinal L-cell line: A possible shift from GLP-1 to glucagon production 175
Cellular and molecular effects of protons: Apoptosis induction and potential implications for cancer therapy 171
Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis 168
A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets 167
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 167
Atorvastatin but not pravastatin impairs mitochondrial function in human pancreatic islets and rat β-cells. Direct effect of oxidative stress 166
Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation 164
Cardiovascular risk profile in subjects with diabetes: Is SCORE2-Diabetes reliable? 162
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 162
Antibiotic use and associated factors in a large sample of hospitalised older people 161
Altered expression of uncoupling protein 2 in GLP-1-producing cells after chronic high glucose exposure: implications for the pathogenesis of diabetes mellitus. 159
Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 157
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 155
Chronic Exposure to GLP-1 Increases GLP-1 Synthesis and Release in a Pancreatic Alpha Cell Line (α-TC1): Evidence of a Direct Effect of GLP-1 on Pancreatic Alpha Cells 154
Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia 154
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 153
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritisation and Network Analysis of New Candidate Genes from the Apoptotic Machinery 151
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 151
High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes 150
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World Experience 149
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 148
Alterazioni lipidiche ed epatiche in soggetti con prediabete identificato in base all'emoglobina glicosilata 148
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 148
Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia 147
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease 147
HbA1c identifies subjects with prediabetes and subclinical left ventricular diastolic dysfunction 146
Circulating coding and long non-coding rnas as potential biomarkers of idiopathic pulmonary fibrosis 145
Clinical and molecular biomarkers for diagnosis and staging of nafld 143
Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: a single lipid center real-world experience 143
Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk 142
Cardiovascular Risk Profile in Subjects With Prediabetes and New-Onset Type 2 Diabetes Identified by HbA1c According to American Diabetes Association Criteria 142
Candidate genes of SARS-CoV-2 gender susceptibility 142
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritisation and Network Analysis of New Candidate Genes from the Apoptotic Machinery (AM) 141
296-3p, miR-298-5p and their downstream networks are causally involved in the higher resistance of mammalian pancreatic α cells to cytokine-induced apoptosis as compared to β cells 141
An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects 141
A molecular systems biomedicine approach to Diabetes: characterization, prioritization and network analysis of new candidate genes from the apoptotic machinery 141
Acute hyperbilirubinemia determines an early subclinical renal damage: Evaluation of tubular biomarkers in cholemic nephropathy 141
Glucagon as a therapeutic approach to severe hypoglycemia: After 100 years, is it still the antidote of insulin? 140
Heart failure and chronic kidney disease in a registry of internal medicine wards 140
(2012). Specifically different microRNAs profiles provide new insights on the molecular mechanisms activated by cytotoxic proinflammatory cytokines in mammalian pancreatic alpha and beta cells 139
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 138
Direct effects of d-chiro-inositol on insulin signaling and glucagon secretion of pancreatic alpha cells 138
Analysis of arterial stiffness and sexual function after adding on pcsk9 inhibitor treatment in male patients with familial hypercholesterolemia: A single lipid center real-world experience 138
Impaired Glucagon Suppression And Reduced Insulin Sensitivity In Subjects With Prediabetes Undergoing Atorvastatin Therapy 137
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 135
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 134
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview 133
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 132
Trattamento dell’ipercolesterolemia nel soggetto con diabete mellito: Aggiornamento sugli approcci terapeutici 132
Acidi grassi polinsaturi omega 3 (PUFA): studio pilota nella terapia della NAFDL 130
Molecular Effects of Chronic Exposure to Palmitate in Intestinal Organoids: A New Model to Study Obesity and Diabetes 128
A molecular Systems Medicine approach to Diabetes Mellitus pinpoints the molecular bases of the higher resistance to cytokine-induced apoptosis of mammalian pancreas α cells respect to β cells 128
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 128
Malnutrition-Related Liver Steatosis, CONUT Score and Poor Clinical Outcomes in an Internal Medicine Department 128
Effetti della glucotossicita' su una linea cellulare di L cellule intestinali (GLUTAg: Ruolo di UCP-2 125
Direct and indirect effects of sars-cov-2 pandemic in subjects with familial hypercholesterolemia: A single lipid-center real-world evaluation 125
Early phase insulin secretion is increased in subjects with normal fasting glucose and metabolic syndrome: a premature feature of beta-cell dysfunction 124
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 124
Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation 123
Separate impact of metabolic syndrome and altered glucose tolerance on early markers of vascular injuries. 123
New treatment options for lipid-lowering therapy in subjects with type 2 diabetes 123
Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people 123
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 123
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 122
Acidi grassi polinsaturi omega 3 (PUFA): studio pilota nella terapia della NAFLD 120
LONG NON-CODING RNA ASSOCIATI AL DIABETE MELLITO. FOCUS SULLE COMPLICANZE MICRO E MACROVASCOLARI 120
Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD 119
Alterazioni molecolari del segnale insulinico e del metabolismo degli FFA in pazienti con NASH 118
Author Correction: Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat β-Cells. Direct Effect of Oxidative Stress 118
Implications of GLP-1 Receptor Agonist on Thyroid Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality and TSH Levels 117
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 117
L’induzione di apoptosi da parte di protoni suggerisce innovative strategie terapeutiche anticancro 117
Acute diabetes complications 116
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 115
Sarcopenia and Appendicular Muscle Mass as Predictors of Impaired Fasting Glucose/Type 2 Diabetes in Elderly Women 115
MiR-296-3p, miR-298-5p and their downstream networks are causally involved in the higher resistance of mammalian pancreatic α cells to cytokine-induced apoptosis as compared to β cells 114
Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta cells 113
Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications 113
Therapeutic options for elderly diabetic subjects: open label, randomized clinical trial of insulin glargine added to oral antidiabetic drugs versus increased dosage of oral antidiabetic drugs 113
High Glucose Exposure Impairs L-Cell Differentiation in Intestinal Organoids: Molecular Mechanisms and Clinical Implications 113
Mitochondrial RNAs as Potential Biomarkers of Functional Impairment in Diabetic Kidney Disease 112
Identification of a New RNA and Protein Integrated Biomarker Panel Associated with Kidney Function Impairment in DKD: Translational Implications 112
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 112
Effect of PCSK9 inhibitors on pulse wave velocity and monocyte-to-HDL-cholesterol ratio in familial hypercholesterolemia subjects: results from a single-lipid-unit real-life setting 112
Deregolazione del miRNoma intracellulare ed extracellulare ed analisi bioinformatica in modelli in vitro di NAFLD e NASH 111
Efficacy of combined therapy with GLP1-RA and SGLT2-I in poorly controlled type 2 diabetes 110
Role of ATP Production and Uncoupling Protein-2 in the Insulin Secretory Defect Induced by Chronic Exposure to High Glucose or Free Fatty Acids and Effects of Peroxisome Proliferator-Activated Receptor-gamma Inhibition 110
Chronic exposure to high leucine impairs glucose-induced insulin release by lowering the ATP to ADP ratio 109
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk 108
CEBPA exerts a specific and biologically important proapoptotic role in pancreatic β cells through its downstream network targets 107
Low advanced glycation end product diet improves the lipid and inflammatory profiles of prediabetic subjects 106
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 106
Thyroid Cancer and Circadian Clock Disruption 106
Totale 14.613
Categoria #
all - tutte 94.861
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.861


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.824 185 252 9 36 308 55 267 69 141 9 59 434
2022/20233.044 257 156 46 310 275 501 10 591 709 18 108 63
2023/20241.449 67 232 73 70 68 309 48 133 17 38 223 171
2024/20256.495 696 850 324 418 1.167 639 242 217 369 535 634 404
2025/202612.407 698 516 2.330 827 1.823 2.306 1.479 282 659 696 415 376
2026/2027161 161 0 0 0 0 0 0 0 0 0 0 0
Totale 28.259